Cite
HARVARD Citation
Hsu, A. et al. (2022). Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphoma. Cancer biology & therapy. 23 (1), pp. 417-423. [Online].